EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vitamin B12 Deficiency, Hyperhomocysteinemia, and Diabetes as Metabolic Determinants of Cardiovascular Risk in Mexican Women

Maria D Ramirez-Villalobos iD, Eric Monterrubio-Flores iD, Manlio Marquez-Murillo iD, Jacqueline Alcalde-Rabanal iD, Teresa Shamah-Levy iD, Otilia Perichart-Perera, Nayeli Macias-Morales, Ismael Campos-Nonato iD

Nutrients · 2025

DOI: 10.3390/nu17223535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Maria D Ramirez-Villalobos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Health Systems Research, National Institute of Public Health, Mexico City C.P. 62100, Mexico. Hauptthemen laut MEDLINE: Hyperhomocysteinemia, Vitamin B 12 Deficiency, Cardiovascular Diseases, Diabetes Mellitus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Public Health, Mexican Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vitamin B12 deficiency, hyperhomocysteinemia, and diabetes are emerging determinants of cardiovascular risk, particularly among women. Early detection and treatment represent an important public health opportunity to reduce the burden of disease and promote health equity.

Objective

We aimed to quantify the prevalence of vitamin B12 deficiency, hyperhomocysteinemia, and diabetes, and to evaluate the potential impact of detecting and addressing these conditions on reducing CVD risk in adult Mexican women.

Methods

We analyzed data from 1197 women aged 20–49 years from Mexico’s 2022–2023 National Health and Nutrition Survey (ENSANUT). Serum vitamin B12, folate, and homocysteine were quantified, and 10-year CVD risk was estimated using Framingham and Globorisk models. Population-attributable fractions and cost–benefit analyses were used to assess preventable CVD cases and the economic feasibility of nationwide vitamin B12 supplementation.

Results

Nationwide, 37.2% of women have vitamin B12 deficiency, and 30.6% have borderline levels. In Southern Mexico, the prevalence of vitamin B12 deficiency is higher, reaching 52.4%. Elevated homocysteine levels were detected in 12.3% of women. The predicted number of preventable CVD cases ranged from 10,000 to 14,000, and the benefit–cost ratio exceeded 1, supporting economic feasibility.

Conclusions

Vitamin B12 deficiency and hyperhomocysteinemia are very common among Mexican women and are associated with an increased cardiovascular risk, especially in those aged 40 to 49. The analysis showed that implementing a national vitamin B12 supplementation strategy could be a cost-effective preventive measure, with a benefit–cost ratio ranging from 1.93 in the base case to 2.98 when broader societal savings are taken into account. These findings highlight the potential of targeted nutritional interventions to reduce the burden of cardiovascular disease in women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperhomocysteinemiaVitamin B 12 DeficiencyCardiovascular DiseasesDiabetes MellitusHumansFemaleMexicoAdultMiddle AgedPrevalenceYoung AdultVitamin B 12Nutrition SurveysHeart Disease Risk FactorsHomocysteineFolic AcidCost-Benefit Analysis

Stichwörter der Autor:innen

MexicoWomen’s healthcardiovascular riskhyperhomocysteinemianational health and nutrition surveypublic healthrisk prediction modelsscalestype 2 diabetesvitamin B12 deficiency

Substanzen

Vitamin B 12HomocysteineFolic Acid

Autor:innen und Institutionen

  • Center for Health Systems Research, National Institute of Public Health, Mexico City C.P. 62100, Mexico.
  • Center for Nutrition and Health Research, National Institute of Public Health, Mexico City C.P. 62100, Mexico.
  • Deputy Directorate of Diagnostic and Treatment Services, National Institute of Cardiology Ignacio Chávez, Mexico City C.P. 14080, Mexico.
  • Center for Survey Research, National Institute of Public Health, Mexico City C.P. 62100, Mexico.
  • Nutrition and Bioprogramming Coordination, National Institute of Perinatology, Mexico City C.P. 11000, Mexico.

ORCID-Profile: Maria D Ramirez-Villalobos, Eric Monterrubio-Flores, Manlio Marquez-Murillo, Jacqueline Alcalde-Rabanal, Teresa Shamah-Levy, Ismael Campos-Nonato

Förderung

  • National Institute of Public Health
  • Mexican Ministry of Health

Zitieren

APA

Ramirez-Villalobos, M. D., Monterrubio-Flores, E., Marquez-Murillo, M., Alcalde-Rabanal, J., Shamah-Levy, T., Perichart-Perera, O., Macias-Morales, N., & Campos-Nonato, I. (2025). Vitamin B12 Deficiency, Hyperhomocysteinemia, and Diabetes as Metabolic Determinants of Cardiovascular Risk in Mexican Women. Nutrients. https://doi.org/10.3390/nu17223535

Vancouver

Ramirez-Villalobos MD, Monterrubio-Flores E, Marquez-Murillo M, Alcalde-Rabanal J, Shamah-Levy T, Perichart-Perera O, et al. Vitamin B12 Deficiency, Hyperhomocysteinemia, and Diabetes as Metabolic Determinants of Cardiovascular Risk in Mexican Women. Nutrients. 2025. doi:10.3390/nu17223535

BibTeX
@article{RamirezVillalobos2025,
  author = {Ramirez-Villalobos, Maria D and Monterrubio-Flores, Eric and Marquez-Murillo, Manlio and Alcalde-Rabanal, Jacqueline and Shamah-Levy, Teresa and Perichart-Perera, Otilia and Macias-Morales, Nayeli and Campos-Nonato, Ismael},
  title = {Vitamin B12 Deficiency, Hyperhomocysteinemia, and Diabetes as Metabolic Determinants of Cardiovascular Risk in Mexican Women},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17223535}
}
Kostenlos starten →